Press Releases
Minnodi Empowers Women
By
April Bartel
|
Frederick, MD: Santhanalakshmi Shanmugam appreciates the unique challenges women face when entering the workforce, especially in the demanding fields of science and technology. She founded Minnodi, LLC, a Maryland-based Women Owned Business focusing … Read more
Betamore & FITCI Announce Founder City
By
Betamore & FITCI
|
Baltimore, MD and Frederick, MD: Betamore and Frederick Innovative Technology Center, Inc. (FITCI) have announced their collaboration on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into … Read more
Leading diagnostics laboratory in the Caribbean selects NextGenPCR for SARS-CoV-2 testing
Clinical implementation of ultra-fast molecular testing improves time to result and laboratory throughput
By
Brian McNally, CEO of VelocidyBio
|
Goes, Netherlands, March 31, 2021 — Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that Aruba’s Laboratorio di Servicio (LdS) has validated and implemented NextGenPCR for SARS-CoV-2 testing. … Read more
M Power Education Records Explosive Growth During the COVID-19 Pandemic
By
Ivana Shuck
|
Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company … Read more
Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
By
Jeff Strovel
|
FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the … Read more
Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia
By
Jeff Strovel, Veralox CEO
|
FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted … Read more
Nanoparticle COVID-19 vaccine REVC-128 potentially induces protection starting two weeks post prime by one dose
By
FITCI
|
Frederick, MD, November 2020 – ReVacc Biotech scientists have designed a multivalent nanoparticle vaccine candidate REVC-128 targeting the current predominant SARS-CoV-2 viral strain with D614G mutation. The preliminary immunogenicity study showed … Read more
Trivance Design Launches Brand New Website
By
Thomas Stein, CEO, Trivance Design
|
Frederick, MD (October 2020) – Trivance Design, a Frederick-based 3D print shop has just announced the launch of their new friendly and easy-to-use website. The site provides information related to the process as well … Read more
Leading the charge on ‘Know your Immunity,’ VirIntel, LLC announces a partnership with Clinical Diagnostic Laboratories (CDL)
By
Kim Gordon, VirInte
|
Frederick, MD (October, 2020 — VirIntel, LLC is excited to announce a partnership with Clinical Diagnostic Laboratories (CDL), one of the top Diagnostics Lab in the DC metro area, to offer the VirIntel COVID-19 … Read more
NANOBIOFAB Awarded a $250,000 Defense Health Agency SBIR grant
Frederick, MD (September 2020) – Nanobiofab, a Frederick-based nanotechnology startup, was awarded a $250,000 Defense Health Agency (DHA) SBIR Program grant for their, “Inkjet assisted Nano printing sensing platform for high-throughput flexible sensors discovery” proposal.
By
Kathie Callahan Brady
|
Nanobiofab has worked continuously to meet the challenge of developing and manufacturing advanced sensing nanomaterials and equipment for the reliable fabrication of wearable and flexible sensors used in medical/health monitoring … Read more

